Serum Claudin-1 (but not IL-17A) levels show a highly significant difference (p = 0.008) between early-onset and late-onset psoriasis patients (Figures 1(b) and 1(e) and Supplementary Table 3). This evidence concerns the gene IL17A and psoriasis.